Full-Time
Senior Cybersecurity Engineer-Software as a Medical Device/Healthcare/Medical Technology
Hybrid or
Posted on 10/31/2025
Q Bio
11-50 employees
Subscription-based preventive health assessments and monitoring
Compensation Overview
$170k - $200k/yr
San Carlos, CA, USA
Hybrid
 IT & Security (1) |
|---|
- Senior Cybersecurity Engineer with experience in embedding security throughout the product lifecycle.
- Design, build, automate, and maintain secure deployment and monitoring of cutting-edge products.
Q.bio provides preventive health care through a subscription model, offering ongoing health assessments like the Q Exam. The Q Exam, about one hour at a Q Center, collects data from blood, saliva, urine, vitals, and whole-body MRI, stored in a BioVault and accessible via a web-based Q Dashboard for telemedicine with doctors, trainers, nutritionists, and other professionals. It differentiates itself by combining multi-source data and an integrated dashboard to identify early signs of disease before symptoms appear, enabling timely interventions for both individuals and clinicians. The goal is to shift healthcare from reactive treatment to proactive, data-driven prevention by giving users continuous, actionable health information and enabling collaboration with healthcare providers.
Company Size
11-50
Company Stage
Late Stage VC
Total Funding
$67M
Headquarters
San Carlos, California
Founded
2015
Simplify's Take
What believers are saying
- Preventive healthcare market expanding as employers and insurers prioritize early disease detection.
- Subscription model with clinician partnerships creates recurring revenue and sticky customer relationships.
- FDA-cleared Constellation software and Gemini Dashboard enable longitudinal health monitoring for personalized medicine.
What critics are saying
- Prenuvo's 15+ established MRI centers undercut Q Bio's first-mover advantage in preventive screening.
- FDA may halt Mark I rollout citing overdiagnosis risks similar to Ezra's regulatory scrutiny.
- Open-source MRI-QAMPER toolkit replicates TFM quantification for free, commoditizing Q Bio's proprietary software.
What makes Q Bio unique
- Tensor Field Mapping delivers quantitative, harmonized MRI data across machines for AI diagnostics.
- Panomics approach integrates imaging, genetics, chemistry, vitals into unified Digital Twin health snapshot.
- Mark I full-body scanner captures 3,000 anatomical measurements in single scan versus multiple traditional scans.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Performance Bonus
Growth & Insights and Company News
6 month growth
↓ -2%1 year growth
↓ -2%2 year growth
↓ -2%Q Bio has secured $27M in funding to advance its Mark I full-body MRI scanner. The investment includes new backer TELUS Global Ventures and existing investors like Khosla Ventures and Andreessen Horowitz. The Mark I scanner, utilizing Tensor Field Mapping technology, offers comprehensive data from 3,000 anatomical measurements in a single scan, eliminating the need for multiple scans.
Q Bio raises $27M in funding round for Mark I MRI scanner.
PALO ALTO, Calif.--(BUSINESS WIRE)--Q Bio Inc., an innovator in medical imaging technology, today announced the launch of Tensor Field Mapping (TFM), a new technology for Magnetic Resonance Imaging (MRI) that provides detailed insights into the human body that were previously unimaginable. Unlike traditional MRIs that provide qualitative data prone to machine or clinical variations, TFM delivers quantitative, harmonized imaging data that can be immediately accessed by AI to accelerate diagnostics. "For decades, MRI technology has been invaluable in diagnosing a wide range of medical conditions, yet it has been limited by its qualitative nature and the variability of the data," said Jeff Kaditz, Founder and CTO / CEO, Q Bio. "With the introduction of Tensor Field Mapping, we are taking a quantum leap forward, making multi-parametric quantification of tissues reproducible across machines, which is key to AI in MRI and personalized medicine.". TFM is the result of extensive research and development by Q Bio's team of experts in medical imaging, physics, and computational science, and will make its debut in the company’s upcoming Mark I full body scanner. The technology provides quantifiable data lacking in traditional MRIs so that properties of tissues can be measured and benchmarked on an ongoing basis
Q Bio launches multiparametric MRI quantification softwre.
Medical imaging company Q Bio announced the launch of a multiparametric MRI upgrade, dubbed Tensor Field Mapping (TFM), designed to provide more detail into the inner-workings of the human body than are currently possible with an MR scanner.